Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sun Life Holding Co. Ltd. (7040:JPX), powered by AI.
Sun Life Holding Co. Ltd. is currently trading at ¥960. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sun Life Holding Co. Ltd. on Alpha Lenz.
Sun Life Holding Co. Ltd.'s P/E ratio is 7.0.
“Sun Life Holding Co. Ltd. trades at a P/E of 7.0 (undervalued) with solid ROE of 13.3%.”
Ask for details →Sun Life Holding Co. Ltd. is a financial holding company primarily involved in the insurance and financial services sectors. The company's main focus is on providing a diverse range of life and health insurance products, catering to both individual and corporate clients. Its offerings include life, health, and pension insurance, alongside investment-linked products that allow policyholders to benefit from the performance of underlying assets. With a presence that extends beyond traditional insurance offerings, Sun Life Holding Co. Ltd. plays a significant role in promoting financial security and planning. It operates in an industry that is crucial for economic stability, offering products that mitigate various financial risks for their clients. The company's reach across different demographics means it supports a broad base of consumers seeking protection, investment, and peace of mind. In the financial market, Sun Life Holding Co. Ltd. is seen as a key player in the insurance industry, influencing the market through its innovative product offerings and strong customer relationships. With its strategic investments and wide distribution network, the company is positioned to address evolving market needs and consumer demands efficiently.
“Sun Life Holding Co. Ltd. trades at a P/E of 7.0 (undervalued) with solid ROE of 13.3%.”
Ask for details →Sun Life Holding Co. Ltd. (ticker: 7040) is a company listed on JPX in the Consumer Cyclical sector (Personal Services). It has approximately 483 employees. Market cap is $5.9B.
The current price is 960 with a P/E ratio of 7.04x and P/B of 0.89x.
ROE is 13.25% and operating margin is 9.42%. Annual revenue is $13.9B.